Global Disodium Ribonucleotides (I+G) Market
完整報告名稱與涵蓋範圍
Global Disodium Ribonucleotides (I+G) Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
報告摘要
According to our (Global Info Research) latest study, the global Disodium Ribonucleotides (I+G) market size was valued at US$ 636 million in 2025 and is forecast to a readjusted size of US$ 798 million by 2032 with a CAGR of 3.5% during review period.
Disodium Ribonucleotides (I+G), commonly known as I+G, is a high-efficiency flavor enhancer composed mainly of disodium inosinate (IMP) and disodium guanylate (GMP). It enhances umami taste by synergistically interacting with monosodium glutamate (MSG), providing stronger flavor intensity with lower usage levels. Disodium Ribonucleotides (I+G) is widely used in food seasoning applications, including MSG and chicken essence, soy sauce, instant noodle seasoning packets, compound seasoning sauces, and other processed food products. This research focuses on Disodium Ribonucleotides (I+G) products with different composition structures, including GMP, IMP, and I+G blended products, covering their production, supply, and application across the global food ingredient market.
Key Findings
Global Disodium Ribonucleotides (I+G) sales reached 75,006 MT in 2025
Average market price reached US$8,245 per MT in 2025
China accounted for 54.10% of global market demand in 2025
Southeast Asia represented 31.66% of global market demand
Top five players accounted for 91.09% of global revenue
Market Trends
The Disodium Ribonucleotides (I+G) industry is moving from a technology introduction stage toward refined operation and global competition. Demand is increasingly influenced by changes in food consumption patterns, including the expansion of ready-to-eat meals, snacks, plant-based foods, and convenience food products. Food manufacturers are also paying greater attention to flavor optimization, sodium reduction solutions, and clean-label product development, which is supporting the continued adoption of Disodium Ribonucleotides (I+G) as an efficient umami enhancer. At the same time, manufacturers are strengthening production efficiency, quality consistency, and customized formulation capabilities to improve competitiveness in a mature market.
Market Dynamics
Drivers
The growth of Disodium Ribonucleotides (I+G) demand is primarily driven by the expansion of processed food consumption, increasing penetration of global chain restaurants, and rising demand for convenient food products. The growth of ready-to-eat meals, instant food, snacks, and compound seasonings continues to create stable application opportunities. In addition, consumers’ preference for reduced-sodium foods without sacrificing taste is strengthening the strategic importance of Disodium Ribonucleotides (I+G), as it can enhance umami intensity and support lower salt formulations.
Restraints
The Disodium Ribonucleotides (I+G) market faces limitations from its relatively mature application structure and high dependence on downstream seasoning industries. Although demand remains stable, market expansion is closely linked to the growth rate of processed foods and foodservice sectors. In addition, strict food safety requirements, quality consistency standards, and production technology barriers increase operational requirements for manufacturers.
Opportunities
Emerging markets, particularly Southeast Asia and Africa, provide additional growth opportunities due to increasing per capita condiment consumption and expansion of processed food industries. The continued development of ready-to-eat meals, plant-based foods, and premium seasoning products creates new application scenarios for Disodium Ribonucleotides (I+G).
Challenges
The Disodium Ribonucleotides (I+G) industry faces challenges from high market concentration, intensified competition among leading producers, and pressure to maintain cost competitiveness. As China has become the global production center with more than 70% of global I+G production capacity, competition is increasingly focused on production efficiency, supply chain advantages, and pricing strategies.
Industry Chain Analysis
The Disodium Ribonucleotides (I+G) industry chain consists of upstream raw materials, fermentation-based manufacturing, and downstream food applications. Upstream production mainly relies on agricultural and biological raw materials required for fermentation processes, while midstream manufacturers use microbial fermentation, extraction, purification, and blending technologies to produce GMP, IMP, and I+G products. Production efficiency, fermentation technology, quality control, and scale advantages determine cost competitiveness.
Segment Insights
The Disodium Ribonucleotides (I+G) market is mainly segmented by product type and application. I+G blended products represent the mainstream commercial form due to their strong synergistic umami enhancement effect when combined with MSG. GMP and IMP products serve as important raw materials for customized formulations and specific applications.
Downstream Market Opportunities
The downstream market for Disodium Ribonucleotides (I+G) is closely connected with the global food processing and seasoning industries. Traditional applications such as MSG, chicken essence, soy sauce, and instant noodle seasoning remain stable demand bases, while emerging categories including ready-to-eat meals, snacks, plant-based foods, and premium sauces are expanding application opportunities.
Competitive Landscape Analysis
The global Disodium Ribonucleotides (I+G) market demonstrates a highly concentrated oligopolistic competitive structure. Major participants include CJ Group, Ajinomoto, Meihua Group, Star Lake Bioscience, Daesang, and Foison Biotechnology. In 2025, the top five players accounted for approximately 91.09% of global revenue, reflecting strong concentration among leading producers. China has become the core global supply base, supported by fermentation capabilities, production scale, and integrated industrial chains.
Report Scope
This report is a detailed and comprehensive analysis for global Disodium Ribonucleotides (I+G) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Disodium Ribonucleotides (I+G) market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2021-2032
Global Disodium Ribonucleotides (I+G) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2021-2032
Global Disodium Ribonucleotides (I+G) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2021-2032
Global Disodium Ribonucleotides (I+G) market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Disodium Ribonucleotides (I+G)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Disodium Ribonucleotides (I+G) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CJ Group, Ajinomoto, Meihua Group, Star Lake Bioscience, Daesang, Foison Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Disodium Ribonucleotides (I+G) market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
GMP
IMP
I+G Type
Market segment by Production Process
Fermentation
Enzymatic Conversion
Semi-Synthesis
Market segment by Product Form
Powder
Granules
Crystals
Market segment by Application
MSG and Chicken Essence
Soy Sauce
Instant Noodle Seasoning Packet
Seasoning Compound Sauce
Others
Major players covered
CJ Group
Ajinomoto
Meihua Group
Star Lake Bioscience
Daesang
Foison Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Disodium Ribonucleotides (I+G) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Disodium Ribonucleotides (I+G), with price, sales quantity, revenue, and global market share of Disodium Ribonucleotides (I+G) from 2021 to 2026.
Chapter 3, the Disodium Ribonucleotides (I+G) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Disodium Ribonucleotides (I+G) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Disodium Ribonucleotides (I+G) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Disodium Ribonucleotides (I+G).
Chapter 14 and 15, to describe Disodium Ribonucleotides (I+G) sales channel, distributors, customers, research findings and conclusion.
授權報價
| Single User License | $3,480 USD |
| Multi User License | $5,220 USD |
| Corporate Users License | $6,960 USD |
目錄 Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Disodium Ribonucleotides (I+G) Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 GMP
1.3.3 IMP
1.3.4 I+G Type
1.4 Market Analysis by Production Process
1.4.1 Overview: Global Disodium Ribonucleotides (I+G) Consumption Value by Production Process: 2021 Versus 2025 Versus 2032
1.4.2 Fermentation
1.4.3 Enzymatic Conversion
1.4.4 Semi-Synthesis
1.5 Market Analysis by Product Form
1.5.1 Overview: Global Disodium Ribonucleotides (I+G) Consumption Value by Product Form: 2021 Versus 2025 Versus 2032
1.5.2 Powder
1.5.3 Granules
1.5.4 Crystals
1.6 Market Analysis by Application
1.6.1 Overview: Global Disodium Ribonucleotides (I+G) Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 MSG and Chicken Essence
1.6.3 Soy Sauce
1.6.4 Instant Noodle Seasoning Packet
1.6.5 Seasoning Compound Sauce
1.6.6 Others
1.7 Global Disodium Ribonucleotides (I+G) Market Size & Forecast
1.7.1 Global Disodium Ribonucleotides (I+G) Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Disodium Ribonucleotides (I+G) Sales Quantity (2021-2032)
1.7.3 Global Disodium Ribonucleotides (I+G) Average Price (2021-2032)
2 Manufacturers Profiles
2.1 CJ Group
2.1.1 CJ Group Details
2.1.2 CJ Group Major Business
2.1.3 CJ Group Disodium Ribonucleotides (I+G) Product and Services
2.1.4 CJ Group Disodium Ribonucleotides (I+G) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 CJ Group Recent Developments/Updates
2.2 Ajinomoto
2.2.1 Ajinomoto Details
2.2.2 Ajinomoto Major Business
2.2.3 Ajinomoto Disodium Ribonucleotides (I+G) Product and Services
2.2.4 Ajinomoto Disodium Ribonucleotides (I+G) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Ajinomoto Recent Developments/Updates
2.3 Meihua Group
2.3.1 Meihua Group Details
2.3.2 Meihua Group Major Business
2.3.3 Meihua Group Disodium Ribonucleotides (I+G) Product and Services
2.3.4 Meihua Group Disodium Ribonucleotides (I+G) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Meihua Group Recent Developments/Updates
2.4 Star Lake Bioscience
2.4.1 Star Lake Bioscience Details
2.4.2 Star Lake Bioscience Major Business
2.4.3 Star Lake Bioscience Disodium Ribonucleotides (I+G) Product and Services
2.4.4 Star Lake Bioscience Disodium Ribonucleotides (I+G) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Star Lake Bioscience Recent Developments/Updates
2.5 Daesang
2.5.1 Daesang Details
2.5.2 Daesang Major Business
2.5.3 Daesang Disodium Ribonucleotides (I+G) Product and Services
2.5.4 Daesang Disodium Ribonucleotides (I+G) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Daesang Recent Developments/Updates
2.6 Foison Biotechnology
2.6.1 Foison Biotechnology Details
2.6.2 Foison Biotechnology Major Business
2.6.3 Foison Biotechnology Disodium Ribonucleotides (I+G) Product and Services
2.6.4 Foison Biotechnology Disodium Ribonucleotides (I+G) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Foison Biotechnology Recent Developments/Updates
3 Competitive Environment: Disodium Ribonucleotides (I+G) by Manufacturer
3.1 Global Disodium Ribonucleotides (I+G) Sales Quantity by Manufacturer (2021-2026)
3.2 Global Disodium Ribonucleotides (I+G) Revenue by Manufacturer (2021-2026)
3.3 Global Disodium Ribonucleotides (I+G) Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Disodium Ribonucleotides (I+G) by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Disodium Ribonucleotides (I+G) Manufacturer Market Share in 2025
3.4.3 Top 6 Disodium Ribonucleotides (I+G) Manufacturer Market Share in 2025
3.5 Disodium Ribonucleotides (I+G) Market: Overall Company Footprint Analysis
3.5.1 Disodium Ribonucleotides (I+G) Market: Region Footprint
3.5.2 Disodium Ribonucleotides (I+G) Market: Company Product Type Footprint
3.5.3 Disodium Ribonucleotides (I+G) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Disodium Ribonucleotides (I+G) Market Size by Region
4.1.1 Global Disodium Ribonucleotides (I+G) Sales Quantity by Region (2021-2032)
4.1.2 Global Disodium Ribonucleotides (I+G) Consumption Value by Region (2021-2032)
4.1.3 Global Disodium Ribonucleotides (I+G) Average Price by Region (2021-2032)
4.2 North America Disodium Ribonucleotides (I+G) Consumption Value (2021-2032)
4.3 Europe Disodium Ribonucleotides (I+G) Consumption Value (2021-2032)
4.4 Asia-Pacific Disodium Ribonucleotides (I+G) Consumption Value (2021-2032)
4.5 South America Disodium Ribonucleotides (I+G) Consumption Value (2021-2032)
4.6 Middle East & Africa Disodium Ribonucleotides (I+G) Consumption Value (2021-2032)
5 Market Segment by Type
5.1 Global Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
5.2 Global Disodium Ribonucleotides (I+G) Consumption Value by Type (2021-2032)
5.3 Global Disodium Ribonucleotides (I+G) Average Price by Type (2021-2032)
6 Market Segment by Application
6.1 Global Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
6.2 Global Disodium Ribonucleotides (I+G) Consumption Value by Application (2021-2032)
6.3 Global Disodium Ribonucleotides (I+G) Average Price by Application (2021-2032)
7 North America
7.1 North America Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
7.2 North America Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
7.3 North America Disodium Ribonucleotides (I+G) Market Size by Country
7.3.1 North America Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2032)
7.3.2 North America Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
8.1 Europe Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
8.2 Europe Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
8.3 Europe Disodium Ribonucleotides (I+G) Market Size by Country
8.3.1 Europe Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2032)
8.3.2 Europe Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
9.1 Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Disodium Ribonucleotides (I+G) Market Size by Region
9.3.1 Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Disodium Ribonucleotides (I+G) Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
10.1 South America Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
10.2 South America Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
10.3 South America Disodium Ribonucleotides (I+G) Market Size by Country
10.3.1 South America Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2032)
10.3.2 South America Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
11.1 Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Disodium Ribonucleotides (I+G) Market Size by Country
11.3.1 Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
12.1 Disodium Ribonucleotides (I+G) Market Drivers
12.2 Disodium Ribonucleotides (I+G) Market Restraints
12.3 Disodium Ribonucleotides (I+G) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Disodium Ribonucleotides (I+G) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Disodium Ribonucleotides (I+G)
13.3 Disodium Ribonucleotides (I+G) Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Disodium Ribonucleotides (I+G) Typical Distributors
14.3 Disodium Ribonucleotides (I+G) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Global Disodium Ribonucleotides (I+G) Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Disodium Ribonucleotides (I+G) Consumption Value by Production Process, (USD Million), 2021 & 2025 & 2032
Table 3. Global Disodium Ribonucleotides (I+G) Consumption Value by Product Form, (USD Million), 2021 & 2025 & 2032
Table 4. Global Disodium Ribonucleotides (I+G) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. CJ Group Basic Information, Manufacturing Base and Competitors
Table 6. CJ Group Major Business
Table 7. CJ Group Disodium Ribonucleotides (I+G) Product and Services
Table 8. CJ Group Disodium Ribonucleotides (I+G) Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. CJ Group Recent Developments/Updates
Table 10. Ajinomoto Basic Information, Manufacturing Base and Competitors
Table 11. Ajinomoto Major Business
Table 12. Ajinomoto Disodium Ribonucleotides (I+G) Product and Services
Table 13. Ajinomoto Disodium Ribonucleotides (I+G) Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Ajinomoto Recent Developments/Updates
Table 15. Meihua Group Basic Information, Manufacturing Base and Competitors
Table 16. Meihua Group Major Business
Table 17. Meihua Group Disodium Ribonucleotides (I+G) Product and Services
Table 18. Meihua Group Disodium Ribonucleotides (I+G) Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Meihua Group Recent Developments/Updates
Table 20. Star Lake Bioscience Basic Information, Manufacturing Base and Competitors
Table 21. Star Lake Bioscience Major Business
Table 22. Star Lake Bioscience Disodium Ribonucleotides (I+G) Product and Services
Table 23. Star Lake Bioscience Disodium Ribonucleotides (I+G) Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Star Lake Bioscience Recent Developments/Updates
Table 25. Daesang Basic Information, Manufacturing Base and Competitors
Table 26. Daesang Major Business
Table 27. Daesang Disodium Ribonucleotides (I+G) Product and Services
Table 28. Daesang Disodium Ribonucleotides (I+G) Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Daesang Recent Developments/Updates
Table 30. Foison Biotechnology Basic Information, Manufacturing Base and Competitors
Table 31. Foison Biotechnology Major Business
Table 32. Foison Biotechnology Disodium Ribonucleotides (I+G) Product and Services
Table 33. Foison Biotechnology Disodium Ribonucleotides (I+G) Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Foison Biotechnology Recent Developments/Updates
Table 35. Global Disodium Ribonucleotides (I+G) Sales Quantity by Manufacturer (2021-2026) & (MT)
Table 36. Global Disodium Ribonucleotides (I+G) Revenue by Manufacturer (2021-2026) & (USD Million)
Table 37. Global Disodium Ribonucleotides (I+G) Average Price by Manufacturer (2021-2026) & (USD/MT)
Table 38. Market Position of Manufacturers in Disodium Ribonucleotides (I+G), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 39. Head Office and Disodium Ribonucleotides (I+G) Production Site of Key Manufacturer
Table 40. Disodium Ribonucleotides (I+G) Market: Company Product Type Footprint
Table 41. Disodium Ribonucleotides (I+G) Market: Company Product Application Footprint
Table 42. Disodium Ribonucleotides (I+G) New Market Entrants and Barriers to Market Entry
Table 43. Disodium Ribonucleotides (I+G) Mergers, Acquisition, Agreements, and Collaborations
Table 44. Global Disodium Ribonucleotides (I+G) Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 45. Global Disodium Ribonucleotides (I+G) Sales Quantity by Region (2021-2026) & (MT)
Table 46. Global Disodium Ribonucleotides (I+G) Sales Quantity by Region (2027-2032) & (MT)
Table 47. Global Disodium Ribonucleotides (I+G) Consumption Value by Region (2021-2026) & (USD Million)
Table 48. Global Disodium Ribonucleotides (I+G) Consumption Value by Region (2027-2032) & (USD Million)
Table 49. Global Disodium Ribonucleotides (I+G) Average Price by Region (2021-2026) & (USD/MT)
Table 50. Global Disodium Ribonucleotides (I+G) Average Price by Region (2027-2032) & (USD/MT)
Table 51. Global Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2026) & (MT)
Table 52. Global Disodium Ribonucleotides (I+G) Sales Quantity by Type (2027-2032) & (MT)
Table 53. Global Disodium Ribonucleotides (I+G) Consumption Value by Type (2021-2026) & (USD Million)
Table 54. Global Disodium Ribonucleotides (I+G) Consumption Value by Type (2027-2032) & (USD Million)
Table 55. Global Disodium Ribonucleotides (I+G) Average Price by Type (2021-2026) & (USD/MT)
Table 56. Global Disodium Ribonucleotides (I+G) Average Price by Type (2027-2032) & (USD/MT)
Table 57. Global Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2026) & (MT)
Table 58. Global Disodium Ribonucleotides (I+G) Sales Quantity by Application (2027-2032) & (MT)
Table 59. Global Disodium Ribonucleotides (I+G) Consumption Value by Application (2021-2026) & (USD Million)
Table 60. Global Disodium Ribonucleotides (I+G) Consumption Value by Application (2027-2032) & (USD Million)
Table 61. Global Disodium Ribonucleotides (I+G) Average Price by Application (2021-2026) & (USD/MT)
Table 62. Global Disodium Ribonucleotides (I+G) Average Price by Application (2027-2032) & (USD/MT)
Table 63. North America Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2026) & (MT)
Table 64. North America Disodium Ribonucleotides (I+G) Sales Quantity by Type (2027-2032) & (MT)
Table 65. North America Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2026) & (MT)
Table 66. North America Disodium Ribonucleotides (I+G) Sales Quantity by Application (2027-2032) & (MT)
Table 67. North America Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2026) & (MT)
Table 68. North America Disodium Ribonucleotides (I+G) Sales Quantity by Country (2027-2032) & (MT)
Table 69. North America Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2026) & (USD Million)
Table 70. North America Disodium Ribonucleotides (I+G) Consumption Value by Country (2027-2032) & (USD Million)
Table 71. Europe Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2026) & (MT)
Table 72. Europe Disodium Ribonucleotides (I+G) Sales Quantity by Type (2027-2032) & (MT)
Table 73. Europe Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2026) & (MT)
Table 74. Europe Disodium Ribonucleotides (I+G) Sales Quantity by Application (2027-2032) & (MT)
Table 75. Europe Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2026) & (MT)
Table 76. Europe Disodium Ribonucleotides (I+G) Sales Quantity by Country (2027-2032) & (MT)
Table 77. Europe Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2026) & (USD Million)
Table 78. Europe Disodium Ribonucleotides (I+G) Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2026) & (MT)
Table 80. Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Type (2027-2032) & (MT)
Table 81. Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2026) & (MT)
Table 82. Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Application (2027-2032) & (MT)
Table 83. Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Region (2021-2026) & (MT)
Table 84. Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity by Region (2027-2032) & (MT)
Table 85. Asia-Pacific Disodium Ribonucleotides (I+G) Consumption Value by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Disodium Ribonucleotides (I+G) Consumption Value by Region (2027-2032) & (USD Million)
Table 87. South America Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2026) & (MT)
Table 88. South America Disodium Ribonucleotides (I+G) Sales Quantity by Type (2027-2032) & (MT)
Table 89. South America Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2026) & (MT)
Table 90. South America Disodium Ribonucleotides (I+G) Sales Quantity by Application (2027-2032) & (MT)
Table 91. South America Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2026) & (MT)
Table 92. South America Disodium Ribonucleotides (I+G) Sales Quantity by Country (2027-2032) & (MT)
Table 93. South America Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2026) & (USD Million)
Table 94. South America Disodium Ribonucleotides (I+G) Consumption Value by Country (2027-2032) & (USD Million)
Table 95. Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Type (2021-2026) & (MT)
Table 96. Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Type (2027-2032) & (MT)
Table 97. Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Application (2021-2026) & (MT)
Table 98. Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Application (2027-2032) & (MT)
Table 99. Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Country (2021-2026) & (MT)
Table 100. Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity by Country (2027-2032) & (MT)
Table 101. Middle East & Africa Disodium Ribonucleotides (I+G) Consumption Value by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Disodium Ribonucleotides (I+G) Consumption Value by Country (2027-2032) & (USD Million)
Table 103. Disodium Ribonucleotides (I+G) Raw Material
Table 104. Key Manufacturers of Disodium Ribonucleotides (I+G) Raw Materials
Table 105. Disodium Ribonucleotides (I+G) Typical Distributors
Table 106. Disodium Ribonucleotides (I+G) Typical Customers
List of Figures
Figure 1. Disodium Ribonucleotides (I+G) Picture
Figure 2. Global Disodium Ribonucleotides (I+G) Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Disodium Ribonucleotides (I+G) Revenue Market Share by Type in 2025
Figure 4. GMP Examples
Figure 5. IMP Examples
Figure 6. I+G Type Examples
Figure 7. Global Disodium Ribonucleotides (I+G) Revenue by Production Process, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Disodium Ribonucleotides (I+G) Revenue Market Share by Production Process in 2025
Figure 9. Fermentation Examples
Figure 10. Enzymatic Conversion Examples
Figure 11. Semi-Synthesis Examples
Figure 12. Global Disodium Ribonucleotides (I+G) Revenue by Product Form, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Disodium Ribonucleotides (I+G) Revenue Market Share by Product Form in 2025
Figure 14. Powder Examples
Figure 15. Granules Examples
Figure 16. Crystals Examples
Figure 17. Global Disodium Ribonucleotides (I+G) Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. Global Disodium Ribonucleotides (I+G) Revenue Market Share by Application in 2025
Figure 19. MSG and Chicken Essence Examples
Figure 20. Soy Sauce Examples
Figure 21. Instant Noodle Seasoning Packet Examples
Figure 22. Seasoning Compound Sauce Examples
Figure 23. Others Examples
Figure 24. Global Disodium Ribonucleotides (I+G) Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Disodium Ribonucleotides (I+G) Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Disodium Ribonucleotides (I+G) Sales Quantity (2021-2032) & (MT)
Figure 27. Global Disodium Ribonucleotides (I+G) Price (2021-2032) & (USD/MT)
Figure 28. Global Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global Disodium Ribonucleotides (I+G) Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of Disodium Ribonucleotides (I+G) by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 Disodium Ribonucleotides (I+G) Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 Disodium Ribonucleotides (I+G) Manufacturer (Revenue) Market Share in 2025
Figure 33. Global Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global Disodium Ribonucleotides (I+G) Consumption Value Market Share by Region (2021-2032)
Figure 35. North America Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 38. South America Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 40. Global Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Type (2021-2032)
Figure 41. Global Disodium Ribonucleotides (I+G) Consumption Value Market Share by Type (2021-2032)
Figure 42. Global Disodium Ribonucleotides (I+G) Average Price by Type (2021-2032) & (USD/MT)
Figure 43. Global Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global Disodium Ribonucleotides (I+G) Revenue Market Share by Application (2021-2032)
Figure 45. Global Disodium Ribonucleotides (I+G) Average Price by Application (2021-2032) & (USD/MT)
Figure 46. North America Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Type (2021-2032)
Figure 47. North America Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America Disodium Ribonucleotides (I+G) Consumption Value Market Share by Country (2021-2032)
Figure 50. United States Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Type (2021-2032)
Figure 54. Europe Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe Disodium Ribonucleotides (I+G) Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 58. France Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Type (2021-2032)
Figure 63. Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific Disodium Ribonucleotides (I+G) Consumption Value Market Share by Region (2021-2032)
Figure 66. China Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 69. India Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Type (2021-2032)
Figure 73. South America Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America Disodium Ribonucleotides (I+G) Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Type (2021-2032)
Figure 79. Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa Disodium Ribonucleotides (I+G) Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa Disodium Ribonucleotides (I+G) Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa Disodium Ribonucleotides (I+G) Consumption Value (2021-2032) & (USD Million)
Figure 86. Disodium Ribonucleotides (I+G) Market Drivers
Figure 87. Disodium Ribonucleotides (I+G) Market Restraints
Figure 88. Disodium Ribonucleotides (I+G) Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of Disodium Ribonucleotides (I+G) in 2025
Figure 91. Manufacturing Process Analysis of Disodium Ribonucleotides (I+G)
Figure 92. Disodium Ribonucleotides (I+G) Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Global Info Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們